FDA approves Afrezza
On June 27, the U.S. Food and Drug Administration (FDA) approved Afrezza (insulin human) Inhalation Powder, a rapid-acting inhaled insulin to improve glycemic control…
Technology
FDA approves drug for treating rare type of non-Hodgkin lymphoma
On July 3, the U.S. Food and Drug Administration (FDA) approved Beleodaq (belinostat) for the treatment of patients with peripheral T-cell lymphoma, a rare…
New MRI technique may help in early diagnosis of Parkinson’s disease
Researchers have developed a simple MRI technique that may help in the early diagnosis of Parkinson’s disease. Read more and read the study abstract.
FDA approves new indication for imaging agent
On June 13, the U.S. Food and Drug Administration (FDA) a new use for Lymphoseek (technetium 99m tilmanocept) Injection, a radioactive diagnostic imaging agent…
USPSTF recommends hepatitis B screening for high-risk people
The U.S. Preventive Services Task Force (USPSTF) has released “Screening for hepatitis B virus infection in nonpregnant adolescents and adults,” which recommends screening in…
Providing optimal care for patients with central catheters
Confused about central catheters? Here’s what you need to know.
Continuous renal replacement therapy: Dialysis for critically ill patients
This technique slowly removes wastes and excess plasma water, helping patients recover from their illness.
FDA allows marketing of military dressing
On April 3, the U.S. Food and Drug Administration (FDA) announced it is allowing marketing of an expandable, multi-sponge wound dressing to control the…
Quiz Time
A nurse working in the intensive care unit administers 100 mg of diazepam I.V. as ordered by the new resident. Although she checks on…
FDA approves new implantable hearing device
On March 20, the U.S. Food and Drug Administration (FDA) approved the first implantable device for people 18 and older with severe or profound…
FDA allows marketing of first device to prevent migraine headaches
On March 11, the U.S. Food and Drug Administration (FDA) allowed marketing of the first device as a preventative treatment for migraine headaches. This…
MARS®: The new frontier in treating acute liver failure
A type of dialysis, MARS removes toxins and replaces lost liver functions.
FDA approves Afrezza
On June 27, the U.S. Food and Drug Administration (FDA) approved Afrezza (insulin human) Inhalation Powder, a rapid-acting inhaled insulin to improve…
FDA approves drug for treating rare type of non-Hodgkin lymphoma
On July 3, the U.S. Food and Drug Administration (FDA) approved Beleodaq (belinostat) for the treatment of patients with peripheral T-cell lymphoma,…
New MRI technique may help in early diagnosis of Parkinson’s disease
Researchers have developed a simple MRI technique that may help in the early diagnosis of Parkinson’s disease. Read more and read the…
FDA approves new indication for imaging agent
On June 13, the U.S. Food and Drug Administration (FDA) a new use for Lymphoseek (technetium 99m tilmanocept) Injection, a radioactive diagnostic…
USPSTF recommends hepatitis B screening for high-risk people
The U.S. Preventive Services Task Force (USPSTF) has released “Screening for hepatitis B virus infection in nonpregnant adolescents and adults,” which recommends…
Providing optimal care for patients with central catheters
Confused about central catheters? Here’s what you need to know.
Continuous renal replacement therapy: Dialysis for critically ill patients
This technique slowly removes wastes and excess plasma water, helping patients recover from their illness.
FDA allows marketing of military dressing
On April 3, the U.S. Food and Drug Administration (FDA) announced it is allowing marketing of an expandable, multi-sponge wound dressing to…
Quiz Time
A nurse working in the intensive care unit administers 100 mg of diazepam I.V. as ordered by the new resident. Although she…
FDA approves new implantable hearing device
On March 20, the U.S. Food and Drug Administration (FDA) approved the first implantable device for people 18 and older with severe…
FDA allows marketing of first device to prevent migraine headaches
On March 11, the U.S. Food and Drug Administration (FDA) allowed marketing of the first device as a preventative treatment for migraine…
MARS®: The new frontier in treating acute liver failure
A type of dialysis, MARS removes toxins and replaces lost liver functions.
Poll
Preferred way to get content
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.
NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.